STECCA, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 407
EU - Europa 148
AS - Asia 104
AF - Africa 20
SA - Sud America 4
Totale 683
Nazione #
US - Stati Uniti d'America 403
IT - Italia 93
SG - Singapore 43
IN - India 36
CN - Cina 23
FI - Finlandia 18
TG - Togo 14
UA - Ucraina 12
DE - Germania 8
SE - Svezia 6
NG - Nigeria 5
CA - Canada 4
AR - Argentina 3
GB - Regno Unito 3
BG - Bulgaria 2
FR - Francia 2
IE - Irlanda 2
RU - Federazione Russa 2
BR - Brasile 1
ID - Indonesia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 683
Città #
Fairfield 54
Chandler 49
Rome 48
Ashburn 37
Singapore 32
Ann Arbor 21
Wilmington 18
Houston 17
Princeton 17
Woodbridge 17
Cambridge 15
Lomé 14
Plano 14
Beijing 13
Boston 13
Santa Clara 12
Seattle 12
San Paolo di Civitate 10
Dearborn 8
Des Moines 8
Cagliari 6
Helsinki 6
Andover 5
Falkenstein 5
Lawrence 5
Jacksonville 4
Millbury 4
Newton Upper Falls 4
Pescara 4
San Diego 4
Toronto 4
Bologna 3
Bussi sul Tirino 3
Federal 3
Castrovillari 2
Dublin 2
London 2
Norwalk 2
Nuvolera 2
Saint-cyprien 2
Sofia 2
Washington 2
Cape Town 1
Changsha 1
Cuneo 1
Falls Church 1
Fuzhou 1
Guangzhou 1
Guiyang 1
Hanoi 1
Jakarta 1
Kunming 1
Latina 1
Los Angeles 1
Mannheim 1
Mantenopolis 1
Marburg 1
Milan 1
Moscow 1
Nanjing 1
New York 1
Palo Del Colle 1
Phoenix 1
San Mateo 1
Shenyang 1
Totale 528
Nome #
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease 87
Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer’s disease: in vitro and in vivo evidence 80
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α 76
Role of astrocytes in major neurological disorders: The evidence and implications 64
Blunting reactive gliosis as a new tool for treatment of Alzheimer Disease: evidence with palmitoylethanolamide 56
Sirtuin modulators control reactive gliosis in an in vitro model of alzheimer's disease 50
ANTIVIRAL EFFECTS OF RESVERATROL ON EPSTEIN BARR VIRUS LATENT AND LYTIC INFECTION 47
Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus-Infected Burkitt's Lymphoma Cells Depending on Viral Latency Program 39
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 36
Palmitoylethanolamide is able to attenuate astrocyte activation and neuroinflammation in models of Alzheimer’s desease 36
Cannabinoids and PPARs: new tools for Alzheimer’s disease treatment. 33
Sirtuins blunt reactive gliosis in an in vitro model of Alzheimer’s disease. 32
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 32
null 16
Is the modulation of reactive astrocytes a promising strategy for AD therapy? Preclinical experience with palmitoylethanolamide 10
Totale 694
Categoria #
all - tutte 2.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 0 16 14 9 9 13 7 1
2020/202140 2 1 0 6 6 0 0 6 1 3 9 6
2021/2022122 1 5 15 0 23 6 1 16 9 12 4 30
2022/2023166 31 36 10 8 18 17 1 11 26 3 2 3
2023/202463 2 12 5 7 4 9 1 6 0 7 5 5
2024/202560 8 6 7 6 18 15 0 0 0 0 0 0
Totale 694